BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30519452)

  • 1. Chondrosarcoma: biology, genetics, and epigenetics.
    Chow WA
    F1000Res; 2018; 7():. PubMed ID: 30519452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on chondrosarcomas.
    Chow WA
    Curr Opin Oncol; 2007 Jul; 19(4):371-6. PubMed ID: 17545802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas.
    Dijkhuizen T; van den Berg E; Molenaar WM; Oosterhuis JW; Dam A; Wiersema J; Schraffordt Koops H; de Jong B
    Cancer Genet Cytogenet; 1994 Sep; 76(2):100-5. PubMed ID: 7923056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
    de Andrea CE; San-Julian M; Bovée JVMG
    Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of chondrosarcoma and related tumors.
    Sandberg AA
    Curr Opin Oncol; 2004 Jul; 16(4):342-54. PubMed ID: 15187889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rb-loss is associated with high malignancy in chondrosarcoma.
    Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
    Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional chondrosarcoma of the rib cage and sternum: clinicopathological and molecular analysis of 27 patients treated at a single institution.
    Abdulfatah E; Rottmann D; Morag Y; Pantanowitz L; Udager AM; Hao W; Lucas DR
    Hum Pathol; 2023 Jun; 136():63-74. PubMed ID: 37019410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical management of chondrosarcoma.
    Riedel RF; Larrier N; Dodd L; Kirsch D; Martinez S; Brigman BE
    Curr Treat Options Oncol; 2009 Apr; 10(1-2):94-106. PubMed ID: 19238552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
    Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
    Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
    Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies for the treatment of chondrosarcomas: targeting integrins.
    Chen JC; Fong YC; Tang CH
    Biomed Res Int; 2013; 2013():396839. PubMed ID: 24490159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
    Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and prognosis of chondrosarcoma of bone.
    Rozeman LB; Hogendoorn PC; Bovée JV
    Expert Rev Mol Diagn; 2002 Sep; 2(5):461-72. PubMed ID: 12271817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.
    Bovée JV; Sciot R; Dal Cin P; Debiec-Rychter M; van Zelderen-Bhola SL; Cornelisse CJ; Hogendoorn PC
    Diagn Mol Pathol; 2001 Dec; 10(4):228-35. PubMed ID: 11763313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of chondrosarcoma of bone.
    Eriksson AI; Schiller A; Mankin HJ
    Clin Orthop Relat Res; 1980; (153):44-66. PubMed ID: 7449231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical approach towards chondrosarcoma.
    Gelderblom H; Hogendoorn PC; Dijkstra SD; van Rijswijk CS; Krol AD; Taminiau AH; Bovée JV
    Oncologist; 2008 Mar; 13(3):320-9. PubMed ID: 18378543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
    Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
    Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.
    Tinoco G; Wilky BA; Paz-Mejia A; Rosenberg A; Trent JC
    Am Soc Clin Oncol Educ Book; 2015; ():e648-55. PubMed ID: 25993236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.